Reasons for the Ban
- Children are more sensitive to the adverse central nervous system (CNS) effects caused by loperamide.
- The safety and efficacy of loperamide for children have not been established.
- The World Health Organization (WHO) supported this recommendation as seen in their Weekly Epidemiological Record dated December 21-28, 1990.
Regulatory Actions and Enforcement
- The National Drug Committee and Bureau of Food and Drugs (BFAD) recommended the ban in the interest of consumer safety.
- Loperamide hydrochloride liquid preparations for children shall no longer be registered for market distribution.
- The BFAD is mandated to ensure that no loperamide liquid preparations for children are introduced or available in the market moving forward.
Effectivity of the Order
- The order takes effect fifteen (15) days after its publication in a newspaper with general circulation.
Legal Authority and Implementation
- The administrative order was issued by the Secretary of Health, Juan M. Flavier, M.D., M.P.H., on November 11, 1992.
- This order serves to protect consumers, particularly pediatric patients, from potential harm associated with loperamide liquid formulations.